Skip to main content

01.11.2015 | Epidemiology

Black breast cancer survivors experience greater upper extremity disability

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Over one-third of breast cancer survivors experience upper extremity disability. Black women present with factors associated with greater upper extremity disability, including: increased body mass index (BMI), more advanced disease stage at diagnosis, and varying treatment type compared with Whites. No prior research has evaluated the relationship between race and upper extremity disability using validated tools and controlling for these factors. Data were drawn from a survey study among 610 women with stage I–III hormone receptor positive breast cancer. The disabilities of the arm, shoulder and hand (QuickDASH) is an 11-item self-administered questionnaire that has been validated for breast cancer survivors to assess global upper extremity function over the past 7 days. Linear regression and mediation analysis estimated the relationships between race, BMI and QuickDASH score, adjusting for demographics and treatment types. Black women (n = 98) had 7.3 points higher average QuickDASH scores than White (n = 512) women (p < 0.001). After adjusting for BMI, age, education, cancer treatment, months since diagnosis, and aromatase inhibitor status, Black women had an average 4-point (95 % confidence interval 0.18–8.01) higher QuickDASH score (p = 0.04) than White women. Mediation analysis suggested that BMI attenuated the association between race and disability by 40 %. Even several years post-treatment, Black breast cancer survivors had greater upper extremity disability, which was partially mediated by higher BMIs. Close monitoring of high BMI Black women may be an important step in reducing disparities in cancer survivorship. More research is needed on the relationship between race, BMI, and upper extremity disability.
Literatur
1.
Zurück zum Zitat Levy EW, Pfalzer LA, Danoff J, Springer BA, McGarvey C, Shieh C-Y, Morehead-Gee A, Gerber LH, Stout NL (2012) Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery. Breast Cancer Res Treat 134(1):315–324CrossRefPubMed Levy EW, Pfalzer LA, Danoff J, Springer BA, McGarvey C, Shieh C-Y, Morehead-Gee A, Gerber LH, Stout NL (2012) Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery. Breast Cancer Res Treat 134(1):315–324CrossRefPubMed
2.
Zurück zum Zitat Banks E, Byles JE, Gibson RE, Rodgers B, Latz IK, Robinson IA, Williamson AB, Jorm LR (2010) Is psychological distress in people living with cancer related to the fact of diagnosis, current treatment or level of disability? Findings from a large Australian study. Med J Aust 193(5):S62PubMed Banks E, Byles JE, Gibson RE, Rodgers B, Latz IK, Robinson IA, Williamson AB, Jorm LR (2010) Is psychological distress in people living with cancer related to the fact of diagnosis, current treatment or level of disability? Findings from a large Australian study. Med J Aust 193(5):S62PubMed
3.
Zurück zum Zitat Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A (2010) Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 102(19):1468–1477PubMedCentralCrossRefPubMed Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A (2010) Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 102(19):1468–1477PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Rietman J, Dijkstra P, Hoekstra H, Eisma W, Szabo B, Groothoff J, Geertzen J (2003) Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 29(3):229–238CrossRefPubMed Rietman J, Dijkstra P, Hoekstra H, Eisma W, Szabo B, Groothoff J, Geertzen J (2003) Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 29(3):229–238CrossRefPubMed
5.
Zurück zum Zitat Voskuil D, van Nes J, Junggeburt J, van de Velde C, Van Leeuwen F, de Haes J (2010) Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients. Ann Oncol 21(10):2094CrossRefPubMed Voskuil D, van Nes J, Junggeburt J, van de Velde C, Van Leeuwen F, de Haes J (2010) Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients. Ann Oncol 21(10):2094CrossRefPubMed
6.
Zurück zum Zitat Rietman J, Geertzen J, Hoekstra H, Baas P, Dolsma W, De Vries J, Groothoff J, Eisma W, Dijkstra P (2006) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32(2):148–152CrossRefPubMed Rietman J, Geertzen J, Hoekstra H, Baas P, Dolsma W, De Vries J, Groothoff J, Eisma W, Dijkstra P (2006) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32(2):148–152CrossRefPubMed
7.
Zurück zum Zitat Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, Greene BT, DeMichele A (2009) Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer 115(16):3631–3639PubMedCentralCrossRefPubMed Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, Greene BT, DeMichele A (2009) Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer 115(16):3631–3639PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Mao JJ, Chung A, Benton A, Hill S, Ungar L, Leonard CE, Hennessy S, Holmes JH (2013) Online discussion of drug side effects and discontinuation among breast cancer survivors. Pharmacoepidemiol Drug Saf 22(3):256–262PubMedCentralCrossRefPubMed Mao JJ, Chung A, Benton A, Hill S, Ungar L, Leonard CE, Hennessy S, Holmes JH (2013) Online discussion of drug side effects and discontinuation among breast cancer survivors. Pharmacoepidemiol Drug Saf 22(3):256–262PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Henry NL, Azzouz F, Desta Z, Li L, Nguyen AT, Lemler S, Hayden J, Tarpinian K, Yakim E, Flockhart DA (2012) Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol 30(9):936–942PubMedCentralCrossRefPubMed Henry NL, Azzouz F, Desta Z, Li L, Nguyen AT, Lemler S, Hayden J, Tarpinian K, Yakim E, Flockhart DA (2012) Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol 30(9):936–942PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Coleman R, Bolten W, Lansdown M, Dale S, Jackisch C, Merkel D, Maass N, Hadji P (2008) Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations. Cancer Treat Rev 34(3):275–282CrossRefPubMed Coleman R, Bolten W, Lansdown M, Dale S, Jackisch C, Merkel D, Maass N, Hadji P (2008) Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations. Cancer Treat Rev 34(3):275–282CrossRefPubMed
11.
Zurück zum Zitat Yoon J, Malin JL, Tao ML, Tisnado DM, Adams JL, Timmer MJ, Ganz PA, Kahn KL (2008) Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Res Treat 108(2):153–165CrossRefPubMed Yoon J, Malin JL, Tao ML, Tisnado DM, Adams JL, Timmer MJ, Ganz PA, Kahn KL (2008) Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Res Treat 108(2):153–165CrossRefPubMed
12.
Zurück zum Zitat Campbell KL, Pusic AL, Zucker DS, McNeely ML, Binkley JM, Cheville AL, Harwood KJ (2012) A prospective model of care for breast cancer rehabilitation: function. Cancer 118(S8):2300–2311CrossRefPubMed Campbell KL, Pusic AL, Zucker DS, McNeely ML, Binkley JM, Cheville AL, Harwood KJ (2012) A prospective model of care for breast cancer rehabilitation: function. Cancer 118(S8):2300–2311CrossRefPubMed
13.
Zurück zum Zitat Blinder VS, Griggs JJ (2013) Health disparities and the cancer survivor. In: Seminars in Oncology, Elsevier: 796–803 Blinder VS, Griggs JJ (2013) Health disparities and the cancer survivor. In: Seminars in Oncology, Elsevier: 796–803
14.
Zurück zum Zitat Paskett ED, Alfano CM, Davidson MA, Andersen BL, Naughton MJ, Sherman A, McDonald PG, Hays J (2008) Breast cancer survivors’ health-related quality of life. Cancer 113(11):3222–3230PubMedCentralCrossRefPubMed Paskett ED, Alfano CM, Davidson MA, Andersen BL, Naughton MJ, Sherman A, McDonald PG, Hays J (2008) Breast cancer survivors’ health-related quality of life. Cancer 113(11):3222–3230PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Green CR, Hart-Johnson T, Loeffler DR (2011) Cancer-related chronic pain. Cancer 117(9):1994–2003CrossRefPubMed Green CR, Hart-Johnson T, Loeffler DR (2011) Cancer-related chronic pain. Cancer 117(9):1994–2003CrossRefPubMed
16.
Zurück zum Zitat Schmitz K, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, Drake BF (2013) Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst 105(18):1344–1354PubMedCentralCrossRefPubMed Schmitz K, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, Drake BF (2013) Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst 105(18):1344–1354PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Schmitz KH, Agurs-Collins T, Neuhouser ML, Pollack L, Gehlert S (2014) Impact of obesity, race, and ethnicity on cancer survivorship. In: Impact of Energy Balance on Cancer Disparities, Springer: 63–90 Schmitz KH, Agurs-Collins T, Neuhouser ML, Pollack L, Gehlert S (2014) Impact of obesity, race, and ethnicity on cancer survivorship. In: Impact of Energy Balance on Cancer Disparities, Springer: 63–90
18.
Zurück zum Zitat Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce JP (1999) Factors associated with weight gain in women after diagnosis of breast cancer. Women’s Healthy Eating and Living Study Group. J Am Diet Assoc 99(10):1212–1221CrossRefPubMed Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce JP (1999) Factors associated with weight gain in women after diagnosis of breast cancer. Women’s Healthy Eating and Living Study Group. J Am Diet Assoc 99(10):1212–1221CrossRefPubMed
19.
Zurück zum Zitat Haas JS, Earle CC, Orav JE, Brawarsky P, Keohane M, Neville BA, Williams DR (2008) Racial segregation and disparities in breast cancer care and mortality. Cancer 113(8):2166–2172PubMedCentralCrossRefPubMed Haas JS, Earle CC, Orav JE, Brawarsky P, Keohane M, Neville BA, Williams DR (2008) Racial segregation and disparities in breast cancer care and mortality. Cancer 113(8):2166–2172PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Dai D (2010) Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit. Health Place 16(5):1038–1052CrossRefPubMed Dai D (2010) Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit. Health Place 16(5):1038–1052CrossRefPubMed
21.
Zurück zum Zitat Russell EF, Kramer MR, Cooper H, Gabram-Mendola S, Senior-Crosby D (2012) Jacob Arriola KR: Metropolitan area racial residential segregation, neighborhood racial composition, and breast cancer mortality. PubMed Cancer Causes Control 23(9):1519–1527CrossRef Russell EF, Kramer MR, Cooper H, Gabram-Mendola S, Senior-Crosby D (2012) Jacob Arriola KR: Metropolitan area racial residential segregation, neighborhood racial composition, and breast cancer mortality. PubMed Cancer Causes Control 23(9):1519–1527CrossRef
22.
Zurück zum Zitat Warner ET, Lin Gomez S (2010) Impact of neighborhood racial composition and metropolitan residential segregation on disparities in breast cancer stage at diagnosis and survival between black and white women in California. J Community Health 35(4):398–408PubMedCentralCrossRefPubMed Warner ET, Lin Gomez S (2010) Impact of neighborhood racial composition and metropolitan residential segregation on disparities in breast cancer stage at diagnosis and survival between black and white women in California. J Community Health 35(4):398–408PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Wheeler SB, Reeder-Hayes KE, Carey LA (2013) Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncol 18(9):986–993CrossRef Wheeler SB, Reeder-Hayes KE, Carey LA (2013) Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncol 18(9):986–993CrossRef
24.
Zurück zum Zitat Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S (2012) Cancer treatment and survivorship statistics. CA: Cancer J Clin 62(4):220–241 Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S (2012) Cancer treatment and survivorship statistics. CA: Cancer J Clin 62(4):220–241
25.
Zurück zum Zitat Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24(9):1357–1362CrossRefPubMed Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24(9):1357–1362CrossRefPubMed
26.
Zurück zum Zitat Togawa K, Ma H, Sullivan-Halley J, Neuhouser ML, Imayama I, Baumgartner KB, Smith AW, Alfano CM, McTiernan A, Ballard-Barbash R (2014) Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study. Breast Cancer Res 16(4):414PubMedCentralCrossRefPubMed Togawa K, Ma H, Sullivan-Halley J, Neuhouser ML, Imayama I, Baumgartner KB, Smith AW, Alfano CM, McTiernan A, Ballard-Barbash R (2014) Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study. Breast Cancer Res 16(4):414PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Mak SS, Yeo W, Lee YM et al (2009) Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer. Hong Kong Med J 15(3):8–12PubMed Mak SS, Yeo W, Lee YM et al (2009) Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer. Hong Kong Med J 15(3):8–12PubMed
28.
Zurück zum Zitat Reeder-Hayes K, Bainbridge J, Meyer A, Amos K, Weiner B, Godley P, Carpenter W (2011) Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat 128(3):863–871PubMedCentralCrossRefPubMed Reeder-Hayes K, Bainbridge J, Meyer A, Amos K, Weiner B, Godley P, Carpenter W (2011) Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat 128(3):863–871PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat American Cancer Society (2013) Breast cancer facts & figures 2013–2014. American Cancer Society, Inc, In., Atlanta American Cancer Society (2013) Breast cancer facts & figures 2013–2014. American Cancer Society, Inc, In., Atlanta
30.
Zurück zum Zitat Morehead-Gee AJ, Pfalzer L, Levy E, McGarvey C, Springer B, Soballe P, Gerber L, Stout NL (2012) Racial disparities in physical and functional domains in women with breast cancer. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 20(8):1839–1847CrossRef Morehead-Gee AJ, Pfalzer L, Levy E, McGarvey C, Springer B, Soballe P, Gerber L, Stout NL (2012) Racial disparities in physical and functional domains in women with breast cancer. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 20(8):1839–1847CrossRef
31.
Zurück zum Zitat Ness KK, Wall MM, Oakes JM, Robison LL, Gurney JG (2006) Physical performance limitations and participation restrictions among cancer survivors: a population-based study. Ann Epidemiol 16(3):197–205CrossRefPubMed Ness KK, Wall MM, Oakes JM, Robison LL, Gurney JG (2006) Physical performance limitations and participation restrictions among cancer survivors: a population-based study. Ann Epidemiol 16(3):197–205CrossRefPubMed
32.
Zurück zum Zitat Gallicchio L, Calhoun C, Helzlsouer KJ (2014) Association between race and physical functioning limitations among breast cancer survivors. Support Cancer: off J Multinatl Assoc Support Care Cancer 22(4):1081–1088CrossRef Gallicchio L, Calhoun C, Helzlsouer KJ (2014) Association between race and physical functioning limitations among breast cancer survivors. Support Cancer: off J Multinatl Assoc Support Care Cancer 22(4):1081–1088CrossRef
33.
Zurück zum Zitat Mao JJ, Su HI, Feng R, Donelson ML, Aplenc R, Rebbeck TR, Stanczyk F, DeMichele A (2011) Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Res 13(1):R8PubMedCentralCrossRefPubMed Mao JJ, Su HI, Feng R, Donelson ML, Aplenc R, Rebbeck TR, Stanczyk F, DeMichele A (2011) Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Res 13(1):R8PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Hudak PL, Amadio PC, Bombardier C (1996) Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand)[corrected]. The upper extremity collaborative group (UECG). Am J Ind Med 29:602–608CrossRefPubMed Hudak PL, Amadio PC, Bombardier C (1996) Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand)[corrected]. The upper extremity collaborative group (UECG). Am J Ind Med 29:602–608CrossRefPubMed
35.
Zurück zum Zitat LeBlanc M, Stineman M, DeMichele A, Stricker C, Mao JJ (2014) Validation of QuickDASH outcome measure in breast cancer survivors for upper extremity disability. Arch Phys Med Rehabil 95(3):493–498PubMedCentralCrossRefPubMed LeBlanc M, Stineman M, DeMichele A, Stricker C, Mao JJ (2014) Validation of QuickDASH outcome measure in breast cancer survivors for upper extremity disability. Arch Phys Med Rehabil 95(3):493–498PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Baron RM, Kenny DA (1986) The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182CrossRefPubMed Baron RM, Kenny DA (1986) The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182CrossRefPubMed
37.
Zurück zum Zitat Judd CM, Kenny DA (1981) Process analysis estimating mediation in treatment evaluations. Evaluation Rev 5(5):602–619CrossRef Judd CM, Kenny DA (1981) Process analysis estimating mediation in treatment evaluations. Evaluation Rev 5(5):602–619CrossRef
38.
Zurück zum Zitat James LR, Brett JM (1984) Mediators, moderators, and tests for mediation. J Appl Psychol 69(2):307CrossRef James LR, Brett JM (1984) Mediators, moderators, and tests for mediation. J Appl Psychol 69(2):307CrossRef
40.
Zurück zum Zitat Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. J Am Med Assoc 307(5):491–497CrossRef Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. J Am Med Assoc 307(5):491–497CrossRef
41.
Zurück zum Zitat Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999-2004. J Am Med Assoc 295(13):1549–1555CrossRef Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999-2004. J Am Med Assoc 295(13):1549–1555CrossRef
42.
Zurück zum Zitat Kumanyika S (1987) Obesity in black women. Epidemiol Rev 9:31–50PubMed Kumanyika S (1987) Obesity in black women. Epidemiol Rev 9:31–50PubMed
43.
Zurück zum Zitat Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL (2006) Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat 97(3):245–254CrossRefPubMed Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL (2006) Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat 97(3):245–254CrossRefPubMed
44.
Zurück zum Zitat Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R (2004) Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 36(9):1484PubMedCentralPubMed Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R (2004) Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 36(9):1484PubMedCentralPubMed
45.
Zurück zum Zitat Ferraro KF, Su Y, Gretebeck RJ, Black DR, Badylak SF (2002) Body mass index and disability in adulthood: a 20-year panel study. Am J Public Health 92(5):834–840PubMedCentralCrossRefPubMed Ferraro KF, Su Y, Gretebeck RJ, Black DR, Badylak SF (2002) Body mass index and disability in adulthood: a 20-year panel study. Am J Public Health 92(5):834–840PubMedCentralCrossRefPubMed
46.
Zurück zum Zitat Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, Kushi LH (2010) Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study. Arch Surg 145(11):1055PubMedCentralCrossRefPubMed Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, Kushi LH (2010) Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study. Arch Surg 145(11):1055PubMedCentralCrossRefPubMed
47.
Zurück zum Zitat Meeske KA, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC, Bernstein L (2009) Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat 113(2):383–391CrossRefPubMed Meeske KA, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC, Bernstein L (2009) Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat 113(2):383–391CrossRefPubMed
48.
Zurück zum Zitat Young A, Weltzien E, Kwan M, Castillo A, Caan B, Kroenke CH (2014) Pre-to post-diagnosis weight change and associations with physical functional limitations in breast cancer survivors. J Cancer Surviv 8(4):539–547CrossRefPubMed Young A, Weltzien E, Kwan M, Castillo A, Caan B, Kroenke CH (2014) Pre-to post-diagnosis weight change and associations with physical functional limitations in breast cancer survivors. J Cancer Surviv 8(4):539–547CrossRefPubMed
49.
Zurück zum Zitat Abdel-Moneim R (1984) The hazards of surgery in the obese. Int Surg 70(2):101–103 Abdel-Moneim R (1984) The hazards of surgery in the obese. Int Surg 70(2):101–103
50.
Zurück zum Zitat Choban PS, Flancbaum L (1997) The impact of obesity on surgical outcomes: a review. J Am Coll Surg 185(6):593–603CrossRefPubMed Choban PS, Flancbaum L (1997) The impact of obesity on surgical outcomes: a review. J Am Coll Surg 185(6):593–603CrossRefPubMed
51.
Zurück zum Zitat Bamgbade OA, Rutter TW, Nafiu OO, Dorje P (2007) Postoperative complications in obese and nonobese patients. World J Surg 31(3):556–560CrossRefPubMed Bamgbade OA, Rutter TW, Nafiu OO, Dorje P (2007) Postoperative complications in obese and nonobese patients. World J Surg 31(3):556–560CrossRefPubMed
52.
Zurück zum Zitat Demark-Wahnefried W, Campbell KL, Hayes SC (2012) Weight management and its role in breast cancer rehabilitation. Cancer 118(S8):2277–2287CrossRefPubMed Demark-Wahnefried W, Campbell KL, Hayes SC (2012) Weight management and its role in breast cancer rehabilitation. Cancer 118(S8):2277–2287CrossRefPubMed
53.
Zurück zum Zitat Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED (2009) The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 49(1):140–147. e141 Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED (2009) The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 49(1):140–147. e141
54.
Zurück zum Zitat Schuster JM, Rechtine G, Norvell DC, Dettori JR (2010) The influence of perioperative risk factors and therapeutic interventions on infection rates after spine surgery: a systematic review. Spine 35(9S):S125–S137CrossRefPubMed Schuster JM, Rechtine G, Norvell DC, Dettori JR (2010) The influence of perioperative risk factors and therapeutic interventions on infection rates after spine surgery: a systematic review. Spine 35(9S):S125–S137CrossRefPubMed
55.
Zurück zum Zitat Anaya DA, Dellinger EP (2006) The obese surgical patient: a susceptible host for infection. Surg Infect 7(5):473–480CrossRef Anaya DA, Dellinger EP (2006) The obese surgical patient: a susceptible host for infection. Surg Infect 7(5):473–480CrossRef
56.
Zurück zum Zitat Poirier P, Alpert MA, Fleisher LA, Thompson PD, Sugerman HJ, Burke LE, Marceau P, Franklin BA (2009) Cardiovascular evaluation and management of severely obese patients undergoing surgery a science advisory from the American Heart Association. Circulation 120(1):86–95CrossRefPubMed Poirier P, Alpert MA, Fleisher LA, Thompson PD, Sugerman HJ, Burke LE, Marceau P, Franklin BA (2009) Cardiovascular evaluation and management of severely obese patients undergoing surgery a science advisory from the American Heart Association. Circulation 120(1):86–95CrossRefPubMed
57.
Zurück zum Zitat Chen CL, Shore AD, Johns R, Clark JM, Manahan M, Makary MA (2011) The impact of obesity on breast surgery complications. Plast Reconstr Surg 128(5):395e–402eCrossRefPubMed Chen CL, Shore AD, Johns R, Clark JM, Manahan M, Makary MA (2011) The impact of obesity on breast surgery complications. Plast Reconstr Surg 128(5):395e–402eCrossRefPubMed
58.
Zurück zum Zitat McCarthy CM, Mehrara BJ, Riedel E, Davidge K, Hinson A, Disa JJ, Cordeiro PG, Pusic AL (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121(6):1886–1892CrossRefPubMed McCarthy CM, Mehrara BJ, Riedel E, Davidge K, Hinson A, Disa JJ, Cordeiro PG, Pusic AL (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121(6):1886–1892CrossRefPubMed
59.
Zurück zum Zitat Selber JC, Kurichi JE, Vega SJ, Sonnad SS, Serletti JM (2006) Risk factors and complications in free TRAM flap breast reconstruction. Ann Plast Surg 56(5):492–497CrossRefPubMed Selber JC, Kurichi JE, Vega SJ, Sonnad SS, Serletti JM (2006) Risk factors and complications in free TRAM flap breast reconstruction. Ann Plast Surg 56(5):492–497CrossRefPubMed
60.
Zurück zum Zitat Hong S, Bardwell WA, Natarajan L, Flatt SW, Rock CL, Newman VA, Madlensky L, Mills PJ, Dimsdale JE, Thomson CA (2007) Correlates of physical activity level in breast cancer survivors participating in the Women’s Healthy Eating and Living (WHEL) Study. Breast Cancer Res Treat 101(2):225–232CrossRefPubMed Hong S, Bardwell WA, Natarajan L, Flatt SW, Rock CL, Newman VA, Madlensky L, Mills PJ, Dimsdale JE, Thomson CA (2007) Correlates of physical activity level in breast cancer survivors participating in the Women’s Healthy Eating and Living (WHEL) Study. Breast Cancer Res Treat 101(2):225–232CrossRefPubMed
61.
Zurück zum Zitat Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, Pierce JP (2012) Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors. Cancer 118(16):4024–4031PubMedCentralCrossRefPubMed Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, Pierce JP (2012) Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors. Cancer 118(16):4024–4031PubMedCentralCrossRefPubMed
62.
Zurück zum Zitat McCormack VA, Perry N, Vinnicombe SJ, dos Santos Silva I (2008) Ethnic variations in mammographic density: a British multiethnic longitudinal study. Am J Epidemiol 168(4):412–421CrossRefPubMed McCormack VA, Perry N, Vinnicombe SJ, dos Santos Silva I (2008) Ethnic variations in mammographic density: a British multiethnic longitudinal study. Am J Epidemiol 168(4):412–421CrossRefPubMed
63.
Zurück zum Zitat Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomark Prev 12(4):332–338 Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomark Prev 12(4):332–338
64.
Zurück zum Zitat del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS (2007) Mammographic breast density and race. Am J Roentgenol 188(4):1147–1150CrossRef del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS (2007) Mammographic breast density and race. Am J Roentgenol 188(4):1147–1150CrossRef
65.
Zurück zum Zitat Krieger N (2000) Refiguring “race” epidemiology: epidemiology, racialized biology, and biological expressions of race relations. Int J Health Serv 30(1):211–216CrossRefPubMed Krieger N (2000) Refiguring “race” epidemiology: epidemiology, racialized biology, and biological expressions of race relations. Int J Health Serv 30(1):211–216CrossRefPubMed
67.
Zurück zum Zitat Campesino M, Saenz DS, Choi M, Krouse RS (2012) Perceived discrimination and ethnic identity among breast cancer survivors. In: Oncology Nursing Forum. Onc Nurs Society: E91–E100 Campesino M, Saenz DS, Choi M, Krouse RS (2012) Perceived discrimination and ethnic identity among breast cancer survivors. In: Oncology Nursing Forum. Onc Nurs Society: E91–E100
68.
Zurück zum Zitat Quach T, Nuru-Jeter A, Morris P, Allen L, Shema SJ, Winters JK, Le GM, Gomez SL (2012) Experiences and perceptions of medical discrimination among a multiethnic sample of breast cancer patients in the Greater San Francisco Bay Area, California. Am J Public Health 102(5):1027–1034PubMedCentralCrossRefPubMed Quach T, Nuru-Jeter A, Morris P, Allen L, Shema SJ, Winters JK, Le GM, Gomez SL (2012) Experiences and perceptions of medical discrimination among a multiethnic sample of breast cancer patients in the Greater San Francisco Bay Area, California. Am J Public Health 102(5):1027–1034PubMedCentralCrossRefPubMed
69.
Zurück zum Zitat Oberst K, Bradley CJ, Schenk M (2008) Breast and prostate cancer patient’s reliability of treatment reporting. J Reg Manag 36(1):12–15 Oberst K, Bradley CJ, Schenk M (2008) Breast and prostate cancer patient’s reliability of treatment reporting. J Reg Manag 36(1):12–15
Metadaten
Titel
Black breast cancer survivors experience greater upper extremity disability
Publikationsdatum
01.11.2015
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2015
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3580-3

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.